X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (336) 336
Patent (199) 199
Publication (122) 122
Book Review (25) 25
Conference Proceeding (6) 6
Book Chapter (3) 3
Newspaper Article (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (236) 236
microbiology (217) 217
human necessities (192) 192
hygiene (190) 190
medical or veterinary science (190) 190
preparations for medical, dental, or toilet purposes (188) 188
biochemistry (185) 185
animals (184) 184
chemistry (182) 182
metallurgy (182) 182
beer (177) 177
culture media (177) 177
enzymology (177) 177
mutation or genetic engineering (177) 177
spirits (177) 177
vinegar (177) 177
wine (177) 177
compositions thereof (176) 176
microorganisms or enzymes (176) 176
propagating, preserving or maintaining microorganisms (176) 176
peptides (148) 148
organic chemistry (144) 144
humans (127) 127
virology (98) 98
immunology (95) 95
viruses (90) 90
vaccines (82) 82
macaca mulatta (76) 76
mice (74) 74
infection (71) 71
hiv (66) 66
hiv-1 - immunology (66) 66
aids vaccines - immunology (65) 65
article (65) 65
rhesus-monkeys (58) 58
immunization (53) 53
vaccines and antiviral agents (53) 53
vaccination (52) 52
simian immunodeficiency virus - immunology (51) 51
female (50) 50
human immunodeficiency virus--hiv (44) 44
immunogenicity (44) 44
infectious diseases (40) 40
vaccine (40) 40
aids vaccines (39) 39
general tagging of cross-sectional technologies spanning over several sections of the ipc (39) 39
general tagging of new technological developments (39) 39
mice, inbred c57bl (39) 39
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (39) 39
technologies or applications for mitigation or adaptation againstclimate change (39) 39
research (38) 38
adenoviridae - genetics (37) 37
antibodies (37) 37
hiv infections - immunology (37) 37
multidisciplinary sciences (37) 37
hiv-1 (36) 36
technologies for adaptation to climate change (36) 36
aids (35) 35
genetic vectors (34) 34
abridged index medicus (33) 33
hiv infections - prevention & control (33) 33
male (33) 33
responses (33) 33
specific therapeutic activity of chemical compounds ormedicinal preparations (33) 33
virus diseases (33) 33
cd8-positive t-lymphocytes - immunology (32) 32
simian acquired immunodeficiency syndrome - immunology (32) 32
health aspects (31) 31
infections (31) 31
neutralizing antibodies (31) 31
prevention (31) 31
immune-responses (30) 30
vaccines, dna - immunology (30) 30
antibodies, neutralizing - immunology (28) 28
in-vivo (28) 28
medical research (28) 28
simian immunodeficiency virus (28) 28
simian immunodeficiency virus - genetics (27) 27
hiv-1 - genetics (26) 26
immunity (26) 26
cd4-positive t-lymphocytes - immunology (25) 25
lymphocytes (25) 25
macaques (25) 25
saids vaccines - immunology (25) 25
t-lymphocytes, cytotoxic - immunology (25) 25
genetic vectors - immunology (24) 24
medicine, research & experimental (24) 24
mice, inbred balb c (24) 24
adenoviruses (23) 23
aids vaccines - administration & dosage (23) 23
immune response (23) 23
viral vaccines - immunology (23) 23
antibodies, viral - immunology (22) 22
molecular sequence data (22) 22
t-lymphocytes - immunology (22) 22
antigens (21) 21
hiv infection (21) 21
simian acquired immunodeficiency syndrome - prevention & control (21) 21
studies (21) 21
vaccines, synthetic - immunology (21) 21
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (535) 535
French (77) 77
German (27) 27
Spanish (6) 6
Chinese (5) 5
Portuguese (5) 5
Japanese (4) 4
Russian (4) 4
Korean (3) 3
Croatian (2) 2
Danish (2) 2
Lithuanian (2) 2
Polish (2) 2
Slovenian (2) 2
Greek (1) 1
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 11/2014, Volume 67, pp. 1 - 1
  Previous work has shown that Ad26/MVA vectors expressing Env/Gag/Pol can afford partial protection against repetitive SIVmac251 and SHIV-SF162P3 challenges... 
Antiretroviral drugs | Vaccines | Monkeys & apes | Human immunodeficiency virus--HIV
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2014, Volume 65, pp. 1 - 1
  We have previously reported the protective efficacy of Ad26/MVA vector regimens expressing SIVsmE543 Env/Gag/Pol antigens against SIVmac251 challenge. Here... 
Proteins | Antigens | Vaccines | Correlation analysis | Monkeys & apes
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 11/2014, Volume 67, p. 46
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2014, Volume 65, Issue Suppl 2, pp. 46 - 46
We have previously reported the protective efficacy of Ad26/MVA vector regimens expressing SIVsmE543 Env/Gag/Pol antigens against SIVmac251 challenge. Here we... 
Abstract
Journal Article
Science, ISSN 0036-8075, 10/2000, Volume 290, Issue 5491, pp. 486 - 492
With accumulating evidence indicating the importance of cytotoxic T lymphocytes (CTLs) in containing human immunodeficiency virus-1 (HIV-1) replication in... 
T lymphocytes | Plasmids | Viremia | DNA | Vaccination | Viruses | DNA vaccines | Research Articles | Epitopes | Viral load | HIV 1 | HIV-1 | PROTEIN | CELL RESPONSES | PROTECTION | IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | INFECTION | MACAQUES | HUMAN-IMMUNODEFICIENCY-VIRUS | CYTOTOXIC T-LYMPHOCYTES | DISEASE PROGRESSION | HIV Antibodies - blood | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neutralization Tests | AIDS Vaccines - therapeutic use | Macaca mulatta | Antibodies, Viral - blood | Viral Load | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | HIV-1 - physiology | Interleukin-2 - immunology | HIV Antibodies - immunology | Simian Acquired Immunodeficiency Syndrome - therapy | Simian Immunodeficiency Virus - immunology | T-Lymphocytes, Cytotoxic - immunology | Lymphocyte Activation | HIV Infections - virology | Acquired Immunodeficiency Syndrome - prevention & control | CD4 Lymphocyte Count | Vaccines, DNA - therapeutic use | HIV-1 - genetics | Disease Progression | Simian Immunodeficiency Virus - physiology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Interleukin-2 - genetics | HIV-1 - immunology | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Virus Replication | HIV Infections - therapy | Antibodies, Viral - immunology | AIDS vaccines | Research | Medical research | HIV | Deoxyribonucleic acid | Human immunodeficiency virus | Vaccines | Monkeys & apes | Human immunodeficiency virus 1 | CD4 antigen | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 22, pp. 2073 - 2076
Journal Article
Journal Article
Immunity, ISSN 1074-7613, 10/2017, Volume 47, Issue 4, pp. 611 - 612
The latent HIV-1 reservoir represents the major barrier for the development of an HIV-1 cure. In this issue of , highlight that effector-to-memory... 
CD4(+) T-CELLS | INFECTION | RESERVOIR | IMMUNOLOGY | RHESUS-MONKEYS | HIV Infections | HIV-1 | CD4-Positive T-Lymphocytes | Virus Latency | Humans | HIV (Viruses) | T cells | Prevention | Cytomegalovirus | Memory cells | Immunological memory | Lymphocytes | Human immunodeficiency virus--HIV | Viruses | Infections | Lymphocytes T | Gene expression | Latency | CD4 antigen | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 07/2017, Volume 547, Issue 7662, pp. 217 - 221
Effective anti-tumour immunity in humans has been associated with the presence of T cells directed at cancer neoantigens(1), a class of HLA-bound peptides that... 
IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | CD4(+) T-CELLS | ANTIGENS | CANCER-IMMUNOTHERAPY | SEQUENCING DATA | EXPRESSION | PEPTIDE | PREDICTION | MOLECULES | EPITOPES | Amino Acid Sequence | Antigens, Neoplasm - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Antigens, Neoplasm - immunology | Humans | Cancer Vaccines - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Cancer Vaccines - chemistry | Antigens, Neoplasm - chemistry | Machine Learning | CD4-Positive T-Lymphocytes - immunology | Neoplasm Recurrence, Local - immunology | Cancer Vaccines - immunology | Histocompatibility Antigens Class II - immunology | Melanoma - genetics | Melanoma - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Patient Safety | High-Throughput Nucleotide Sequencing | Mutation | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Precision Medicine - methods | Care and treatment | Methods | Melanoma | Cancer | Peptides | PD-1 protein | CD8 antigen | Vaccination | Feasibility analysis | Lymphocytes T | Vaccines | Tissues | Immunity | Thymus | Lymphocytes | Immunotherapy | Antigens | Feasibility studies | T cell receptors | Gene expression | Patients | Immunological tolerance | CD4 antigen | Studies | Immune checkpoint | Immunogenicity | Cell death | Histocompatibility antigen HLA | Tumors | Apoptosis | Index Medicus
Journal Article
PLoS pathogens, ISSN 1553-7366, 2016, Volume 12, Issue 3, pp. e1005456 - e1005456
Journal Article
Journal Article
Science, ISSN 0036-8075, 09/2016, Volume 353, Issue 6304, pp. 1129 - 1132
Journal Article
Nature, ISSN 0028-0836, 06/2016, Volume 536, Issue 7617, pp. 474 - 478
Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas(1,2). ZIKV has been causally associated with fetal... 
CHALLENGE | HEALTHY-ADULTS | IMMUNOGENICITY | AMERICA | NEUTRALIZING ANTIBODY | SAFETY | MULTIDISCIPLINARY SCIENCES | INFECTION | MICE | MODEL | Antibody Specificity | Immunoglobulin G - isolation & purification | Vaccines, DNA - genetics | Zika Virus - genetics | Vaccines, Subunit - genetics | Humans | Viral Vaccines - genetics | Vaccines, DNA - immunology | Adoptive Transfer | Microcephaly - virology | CD4-Positive T-Lymphocytes - immunology | Zika Virus Infection - virology | Antibodies, Neutralizing - immunology | Immunoglobulin G - immunology | Gene Deletion | Brazil | Zika Virus Infection - complications | Female | Zika Virus Infection - prevention & control | Zika Virus - immunology | Microcephaly - complications | Vaccines, Inactivated - genetics | Viral Envelope Proteins - genetics | Vaccines, Subunit - chemistry | Vaccines, Subunit - immunology | Zika Virus - chemistry | Vaccines, DNA - chemistry | Vaccines, Inactivated - immunology | Animals | Viral Envelope Proteins - chemistry | Viral Vaccines - chemistry | Zika Virus Infection - immunology | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | Vaccines, Inactivated - chemistry | Product development | Viral vaccines | Studies | Epidemics | Encephalitis | Immunization | Fetuses | Zika virus | Vaccines | Microcephaly | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article